Skip to the page

Data / Form D filings / TELA Bio, Inc.

TELA Bio, Inc.: Form D filings

TELA Bio, Inc., a biotechnology company in Malvern, PA, filed 12 Form D notices with the SEC between 2012 and 2019. The latest, on July 10, 2019, reports $10.6 million sold of a $20 million offering to 15 investors.

Find out what TELA Bio, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1 GREAT VALLEY PARKWAY, SUITE 24, Malvern, PA, 19355
Phone
(484) 320-2930
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1561921

The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 10, 2019New notice$20,000,000$10,623,181$9,376,81915Jun 28, 2019sec.gov
Dec 4, 2018New notice$3,500,000$2,067,080$1,432,9208Nov 20, 2018sec.gov
May 14, 2018New notice$2,000,000$501,120$1,498,8801Apr 30, 2018sec.gov
May 4, 2018New notice$240,000$240,000$01Apr 26, 2018sec.gov
Apr 20, 2018New notice$500,000$500,000$01Apr 13, 2018sec.gov
Apr 2, 2018New notice$1,000,000$500,000$500,0001Mar 23, 2018sec.gov
Nov 2, 2017New notice$25,000,000$15,000,000$10,000,0001Oct 23, 2017sec.gov
Jan 27, 2017New notice$7,500,000$7,386,295$113,70516Jan 18, 2017sec.gov
Nov 24, 2014New notice$500,000$500,000$01Nov 20, 2014sec.gov
Oct 8, 2014New notice$45,370,140$45,370,140$029Oct 2, 2014sec.gov
Aug 14, 2013New notice$6,000,000$6,000,000$016Aug 13, 2013sec.gov
Dec 6, 2012New notice$16,152,500$16,152,500$015Dec 3, 2012sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Antony KoblishExecutive Officer, Director
Ashley FriedmanDirector
Matt ZugaDirector
Kurt AzarbarzinDirector
Nora J. BrennanExecutive Officer
Adele OlivaDirector
Maarten PersenaireExecutive Officer
Francis ConwayExecutive Officer
Ronald J. Ellis, Jr.Director
Vince BurgessDirector

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Jul 8, 2019 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what TELA Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.